Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials
Top Cited Papers
- 30 June 2014
- journal article
- review article
- Published by Elsevier BV in European Urology
- Vol. 66 (1), 42-54
- https://doi.org/10.1016/j.eururo.2013.08.033
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma—Neoadjuvant and Adjuvant SettingsEuropean Urology, 2013
- A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder CancerEuropean Urology, 2012
- Randomized Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987Journal of Clinical Oncology, 2012
- Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trialAnnals of Oncology, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Phase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 StatusJournal of Clinical Oncology, 2011
- Intention-to-treat concept: A reviewPerspectives in Clinical Research, 2011
- Complete long‐term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancerBJU International, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- Advanced methods in meta‐analysis: multivariate approach and meta‐regressionStatistics in Medicine, 2002